Perspectives
This Rare Disease Day, Canadian families living with rare disease have much to celebrate — and even more to look forward to
Faster access to breakthrough therapies is transforming care for Canadians with rare diseases — and the next phase of the RDDS will focus on proving their real-world impact and ensuring that progress becomes permanent.
Industry Voice
In conversation with Gilead Canada’s Christophe Griolet
Industry Voice sat down with Christophe Griolet, General Manager of Gilead Sciences Canada, to discuss how he applies global learnings in a local context, his commitment to health equity, and the incredible promise of personalized medicine.
